These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23235148)

  • 81. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
    Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
    Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ubiquitin-Binding Protein CG5445 Suppresses Aggregation and Cytotoxicity of Amyotrophic Lateral Sclerosis-Linked TDP-43 in Drosophila.
    Uechi H; Kuranaga E; Iriki T; Takano K; Hirayama S; Miura M; Hamazaki J; Murata S
    Mol Cell Biol; 2018 Feb; 38(3):. PubMed ID: 29109084
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions.
    Furukawa Y; Kaneko K; Watanabe S; Yamanaka K; Nukina N
    J Biol Chem; 2011 May; 286(21):18664-72. PubMed ID: 21454603
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis.
    Wu CH; Fallini C; Ticozzi N; Keagle PJ; Sapp PC; Piotrowska K; Lowe P; Koppers M; McKenna-Yasek D; Baron DM; Kost JE; Gonzalez-Perez P; Fox AD; Adams J; Taroni F; Tiloca C; Leclerc AL; Chafe SC; Mangroo D; Moore MJ; Zitzewitz JA; Xu ZS; van den Berg LH; Glass JD; Siciliano G; Cirulli ET; Goldstein DB; Salachas F; Meininger V; Rossoll W; Ratti A; Gellera C; Bosco DA; Bassell GJ; Silani V; Drory VE; Brown RH; Landers JE
    Nature; 2012 Aug; 488(7412):499-503. PubMed ID: 22801503
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons.
    van Eersel J; Ke YD; Gladbach A; Bi M; Götz J; Kril JJ; Ittner LM
    PLoS One; 2011; 6(7):e22850. PubMed ID: 21829535
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inhibition of TDP-43 aggregation by nucleic acid binding.
    Huang YC; Lin KF; He RY; Tu PH; Koubek J; Hsu YC; Huang JJ
    PLoS One; 2013; 8(5):e64002. PubMed ID: 23737961
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Characterization of β-domains in C-terminal fragments of TDP-43 by scanning tunneling microscopy.
    Xu M; Zhu L; Liu J; Yang Y; Wu JY; Wang C
    J Struct Biol; 2013 Jan; 181(1):11-6. PubMed ID: 23138004
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life.
    Austin JA; Wright GS; Watanabe S; Grossmann JG; Antonyuk SV; Yamanaka K; Hasnain SS
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4309-14. PubMed ID: 24591609
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Phenotypic diversity in ALS and the role of poly-conformational protein misfolding.
    Ayers JI; Borchelt DR
    Acta Neuropathol; 2021 Jul; 142(1):41-55. PubMed ID: 32930869
    [TBL] [Abstract][Full Text] [Related]  

  • 90. TDP-43 in ALS: stay on target…almost there.
    Jovičić A; Gitler AD
    Neuron; 2014 Feb; 81(3):463-5. PubMed ID: 24507183
    [TBL] [Abstract][Full Text] [Related]  

  • 91. RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond.
    Hanson KA; Kim SH; Tibbetts RS
    Wiley Interdiscip Rev RNA; 2012; 3(2):265-85. PubMed ID: 22028183
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia.
    Tam OH; Rozhkov NV; Shaw R; Kim D; Hubbard I; Fennessey S; Propp N; ; Fagegaltier D; Harris BT; Ostrow LW; Phatnani H; Ravits J; Dubnau J; Gale Hammell M
    Cell Rep; 2019 Oct; 29(5):1164-1177.e5. PubMed ID: 31665631
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The influence of pathological mutations and proline substitutions in TDP-43 glycine-rich peptides on its amyloid properties and cellular toxicity.
    Sun CS; Wang CY; Chen BP; He RY; Liu GC; Wang CH; Chen W; Chern Y; Huang JJ
    PLoS One; 2014; 9(8):e103644. PubMed ID: 25090004
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Atomistic Insights into A315E Mutation-Enhanced Pathogenicity of TDP-43 Core Fibrils.
    Li F; Chen Y; Liu X; Tang Y; Dong X; Wei G
    ACS Chem Neurosci; 2022 Sep; 13(18):2743-2754. PubMed ID: 36053560
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Novel insights into the structural changes induced by disease-associated mutations in TDP-43: a computational approach.
    Sharma A; Dey P
    J Biomol Struct Dyn; 2023; 41(12):5624-5634. PubMed ID: 35751132
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Importance of the Q/N-rich segment for protein stability of endogenous mouse TDP-43.
    Sato T; Oda K; Sakai S; Kato R; Yamamori S; Itakura M; Kodera Y; Nishizawa M; Sasaoka T; Onodera O; Yokoyama M
    Sci Rep; 2022 Sep; 12(1):14923. PubMed ID: 36056157
    [TBL] [Abstract][Full Text] [Related]  

  • 97. ALS-Linked A315T and A315E Mutations Enhance β-Barrel Formation of the TDP-43
    Liu X; Li X; Qiao Q; Li F; Wei G
    ACS Chem Neurosci; 2023 Apr; 14(7):1310-1320. PubMed ID: 36888995
    [TBL] [Abstract][Full Text] [Related]  

  • 98. ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export.
    Boehringer A; Garcia-Mansfield K; Singh G; Bakkar N; Pirrotte P; Bowser R
    Sci Rep; 2017 Nov; 7(1):14529. PubMed ID: 29109432
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization.
    Malik AM; Miguez RA; Li X; Ho YS; Feldman EL; Barmada SJ
    Elife; 2018 Jul; 7():. PubMed ID: 30015619
    [TBL] [Abstract][Full Text] [Related]  

  • 100. TDP-43 regulates its mRNA levels through a negative feedback loop.
    Ayala YM; De Conti L; Avendaño-Vázquez SE; Dhir A; Romano M; D'Ambrogio A; Tollervey J; Ule J; Baralle M; Buratti E; Baralle FE
    EMBO J; 2011 Jan; 30(2):277-88. PubMed ID: 21131904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.